Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
30.96
+0.17
+(0.55%)
As of 8:44:38 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
2,769,000
--
--
--
--
Operating Cash Flow
2,768,986
2,768,986
2,987,802
2,143,980
2,017,536
Investing Cash Flow
-2,678,115
-2,678,115
-2,072,789
-1,029,421
-1,870,280
Financing Cash Flow
361,145
361,145
-2,148,754
-944,856
385,112
End Cash Position
929,026
929,026
477,010
1,710,751
1,541,048
Issuance of Debt
1,471,235
1,471,235
350,000
--
1,272,533
Repayment of Debt
--
--
-1,350,000
--
--
Repurchase of Capital Stock
-229,651
-229,651
-304,759
--
--
Free Cash Flow
2,768,986
2,768,986
2,987,802
2,143,980
2,017,536
12/31/2021 - 10/13/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HQ1.MU Oruka Therapeutics Inc. R
9.60
0.00%
5KW.F SkinBioTherapeutics plc
0.2160
-2.70%
5CV.MU CureVac NV
2.8900
+0.35%
AM6.F Amicus Therapeutics, Inc.
8.40
-1.18%
ICY.SG Incyte Corp
64.00
-0.47%
600161.SS TIANTAN BIO
19.88
+0.05%
GON.DU Geron Corp
1.5600
+0.13%
1S9.SG Seres Therapeutics Inc
0.6902
+1.77%
ISI.F Ionis Pharmaceuticals, Inc.
31.00
-0.06%
2H51.DU Ocugen Inc
0.5390
+3.95%